Continuing, Withdrawing, and Withholding Medical Treatment at the End of Life and Associated Characteristics: a Mortality Follow-back Study.
end-of-life decisions
medical decision-making
palliative care
withholding treatment
Journal
Journal of general internal medicine
ISSN: 1525-1497
Titre abrégé: J Gen Intern Med
Pays: United States
ID NLM: 8605834
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
24
08
2018
accepted:
22
08
2019
revised:
18
04
2019
pubmed:
28
10
2019
medline:
15
5
2021
entrez:
27
10
2019
Statut:
ppublish
Résumé
Studies on forgoing treatment often ignore treatments that are continued until death. To investigate how often specific treatments are withdrawn or withheld before death and to describe the associated patient, physician, and care characteristics. National mortality follow-back study in Switzerland in 2013/2014 using a standardized survey to collect information on the patient's end of life and demographics on the physician. A random sample of adults who died non-suddenly without an external cause and who had met the physician completing the survey (N = 3051). Any of nine specific treatments was continued until death, withdrawn, or withheld. In 2242 cases (84%), at least one treatment was either continued until death or withheld or withdrawn. The most common treatment was artificial hydration, which was continued in 23%, withdrawn in 4%, and withheld in 22% of all cases. The other eight treatments were withdrawn or withheld in 70-94% of applicable cases. The impact of physician characteristics was limited, but artificial hydration, antibiotics, artificial nutrition, and ventilator therapy were more likely to be withheld at home and in nursing homes than in the hospitals. Large differences exist between care settings in whether treatments are continued, withdrawn, or withheld, indicating the different availability of treatment options or different philosophies of care. While certain patient groups are more likely to have treatment withheld rather than attempted, neither patient nor physician characteristics impact the decision to continue or withdraw treatment.
Sections du résumé
BACKGROUND
Studies on forgoing treatment often ignore treatments that are continued until death.
OBJECTIVE
To investigate how often specific treatments are withdrawn or withheld before death and to describe the associated patient, physician, and care characteristics.
DESIGN
National mortality follow-back study in Switzerland in 2013/2014 using a standardized survey to collect information on the patient's end of life and demographics on the physician.
PARTICIPANTS
A random sample of adults who died non-suddenly without an external cause and who had met the physician completing the survey (N = 3051).
MAIN MEASURES
Any of nine specific treatments was continued until death, withdrawn, or withheld.
KEY RESULTS
In 2242 cases (84%), at least one treatment was either continued until death or withheld or withdrawn. The most common treatment was artificial hydration, which was continued in 23%, withdrawn in 4%, and withheld in 22% of all cases. The other eight treatments were withdrawn or withheld in 70-94% of applicable cases. The impact of physician characteristics was limited, but artificial hydration, antibiotics, artificial nutrition, and ventilator therapy were more likely to be withheld at home and in nursing homes than in the hospitals.
CONCLUSIONS
Large differences exist between care settings in whether treatments are continued, withdrawn, or withheld, indicating the different availability of treatment options or different philosophies of care. While certain patient groups are more likely to have treatment withheld rather than attempted, neither patient nor physician characteristics impact the decision to continue or withdraw treatment.
Identifiants
pubmed: 31654360
doi: 10.1007/s11606-019-05344-5
pii: 10.1007/s11606-019-05344-5
pmc: PMC6957664
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
126-132Références
Soc Sci Med. 2005 May;60(9):1961-74
pubmed: 15743647
Multidiscip Respir Med. 2014 Mar 11;9(1):14
pubmed: 24618004
Support Care Cancer. 2014 Dec;22(12):3287-99
pubmed: 25084741
Arch Intern Med. 2005 Feb 28;165(4):401-7
pubmed: 15738368
Palliat Med. 2014 Sep;28(8):1000-25
pubmed: 24651708
J Pain Symptom Manage. 2014 Jan;47(1):1-11
pubmed: 23742734
Intensive Care Med. 2003 Nov;29(11):1902-10
pubmed: 13680120
Cancer. 2015 Sep 15;121(18):3307-15
pubmed: 26031241
J Clin Oncol. 2008 Aug 10;26(23):3860-6
pubmed: 18688053
Swiss Med Wkly. 2016 Mar 02;146:w14307
pubmed: 26934515
JAMA Oncol. 2015 Sep;1(6):778-84
pubmed: 26203912
Eur J Health Econ. 2016 Apr;17(3):257-67
pubmed: 25749894
Intensive Care Med. 1997 Dec;23(12):1264-7
pubmed: 9470083
PLoS One. 2014 Jan 21;9(1):e84905
pubmed: 24465450
JAMA Intern Med. 2016 Apr;176(4):555-6
pubmed: 26927307
J Am Geriatr Soc. 2015 Feb;63(2):290-6
pubmed: 25641376
J Am Geriatr Soc. 2014 Apr;62(4):706-10
pubmed: 24697553
Crit Care. 2008;12(1):R13
pubmed: 18279501
BMC Health Serv Res. 2014 Oct 25;14:496
pubmed: 25410710
J Clin Oncol. 2002 Dec 15;20(24):4699-704
pubmed: 12488416
Soc Sci Med. 2012 Apr;74(8):1282-7
pubmed: 22401644
JAMA. 2013 Aug 28;310(8):797-8
pubmed: 23896967
J Med Ethics. 2015 Aug;41(8):599-606
pubmed: 25182697
J Med Ethics. 2015 Sep;41(9):766-70
pubmed: 25896928
JAMA. 2016 Jan 19;315(3):284-92
pubmed: 26784776
Clin Nutr. 2016 Jun;35(3):545-56
pubmed: 26923519
Arch Intern Med. 2000 Feb 14;160(3):357-63
pubmed: 10668838
Arch Intern Med. 2006 Apr 24;166(8):921-9
pubmed: 16636220
Palliat Med. 2019 Feb;33(2):213-220
pubmed: 30516090